• LAST PRICE
    49.7000
  • TODAY'S CHANGE (%)
    Trending Up2.8500 (6.0832%)
  • Bid / Lots
    49.6500/ 2
  • Ask / Lots
    49.7500/ 3
  • Open / Previous Close
    47.3200 / 46.8500
  • Day Range
    Low 47.0000
    High 49.8650
  • 52 Week Range
    Low 38.6000
    High 70.7800
  • Volume
    600,601
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 46.85
TimeVolumeLEGN
09:32 ET147347.38
09:34 ET150047.27
09:36 ET40047.265
09:38 ET1260347.49
09:39 ET235147.97
09:41 ET200048.05
09:43 ET115048.3
09:45 ET214148.47
09:48 ET310948.455
09:50 ET120048.57
09:52 ET323648.58
09:54 ET157048.59
09:56 ET235048.55
09:57 ET365048.41
09:59 ET36148.39
10:01 ET690548.6
10:03 ET375548.8
10:06 ET283148.86
10:08 ET210048.74
10:10 ET230048.84
10:12 ET155448.74
10:14 ET115048.61
10:15 ET487948.52
10:17 ET391248.52
10:19 ET270048.535
10:21 ET272948.545
10:24 ET625248.48
10:26 ET282748.59
10:28 ET343748.63
10:30 ET50048.575
10:32 ET60048.565
10:33 ET564948.39
10:35 ET215248.435
10:37 ET187048.57
10:39 ET1373248.72
10:42 ET1555648.965
10:44 ET85049.12
10:46 ET70049.13
10:48 ET80049.31
10:50 ET250349.32
10:51 ET1158549.04
10:53 ET316349.03
10:55 ET1162849.095
10:57 ET120049.105
11:00 ET147949.095
11:02 ET70049.095
11:04 ET615049
11:06 ET1045549
11:08 ET1978649.02
11:09 ET544048.93
11:11 ET332648.99
11:13 ET128449.0122
11:15 ET131849.02
11:18 ET105748.985
11:20 ET4653749
11:22 ET325149.08
11:24 ET239349.18
11:26 ET60049.12
11:27 ET90049.135
11:29 ET621449.21
11:31 ET186049.08
11:33 ET69949.08
11:36 ET259549.08
11:38 ET174349.04
11:40 ET102348.98
11:42 ET1924549.03
11:44 ET3116849.03
11:45 ET427949.04
11:47 ET114849.03
11:49 ET486349.1
11:51 ET199549.16
11:54 ET91649.13
11:56 ET88149.11
11:58 ET20049.125
12:00 ET223349.19
12:02 ET70049.19
12:03 ET328349.34
12:05 ET228849.43
12:07 ET260449.36
12:09 ET65049.39
12:12 ET20049.35
12:14 ET40049.22
12:16 ET20049.22
12:18 ET127849.1
12:20 ET1185249.09
12:21 ET1274649.12
12:23 ET121649.09
12:25 ET82249.06
12:27 ET20649.06
12:30 ET30049.06
12:32 ET234749.13
12:34 ET170849.11
12:36 ET82249.07
12:39 ET10049.065
12:41 ET132749.05
12:43 ET124149
12:45 ET73349.035
12:48 ET760549.405
12:50 ET140349.44
12:52 ET60049.39
12:54 ET10049.33
12:56 ET91149.32
12:57 ET416049.52
12:59 ET92649.51
01:01 ET70049.45
01:03 ET40049.42
01:06 ET30049.465
01:08 ET205849.375
01:10 ET361049.49
01:12 ET37249.43
01:14 ET22649.445
01:15 ET131449.45
01:17 ET147449.475
01:19 ET102749.48
01:21 ET93949.46
01:24 ET291049.39
01:26 ET191849.53
01:28 ET22049.6
01:30 ET254249.745
01:32 ET131849.71
01:33 ET122849.71
01:35 ET91149.705
01:37 ET107449.76
01:39 ET42449.69
01:42 ET1125649.65
01:44 ET176549.74
01:46 ET12149.74
01:48 ET81749.755
01:50 ET82349.8
01:51 ET31549.835
01:53 ET60049.83
01:55 ET62049.81
01:57 ET249449.8
02:00 ET378749.71
02:02 ET30049.7
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLEGN
Legend Biotech Corp
8.6B
-31.7x
---
United StatesASND
Ascendis Pharma A/S
8.9B
-15.2x
---
United StatesITCI
Intra-Cellular Therapies Inc
7.7B
-85.5x
---
United StatesTEM
Tempus AI Inc
8.0B
-6.6x
---
United StatesRVMD
Revolution Medicines Inc
7.3B
-12.2x
---
United StatesBPMC
Blueprint Medicines Corp
5.6B
-27.6x
---
As of 2024-09-27

Company Information

Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.

Contact Information

Headquarters
2101 Cottontail LaneSOMERSET, NJ, United States 08873
Phone
732-317-5050
Fax
---

Executives

Chairman of the Board
Fangliang Zhang
Chief Executive Officer, Director
Ying Huang
Chief Financial Officer
Lori Macomber
Director
Ye Wang
Director
Li Zhu

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$8.6B
Revenue (TTM)
$456.0M
Shares Outstanding
184.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.10
EPS
$-1.57
Book Value
$6.88
P/E Ratio
-31.7x
Price/Sales (TTM)
18.9
Price/Cash Flow (TTM)
---
Operating Margin
-81.89%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.